Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2120 Neoplasms, Plasma Cell 505 Lymphoma 354 Lymphoma, Non-Hodgkin 334 Hodgkin Disease 329 Leukemia, Lymphocytic, Chronic, B-Cell 307 Precursor Cell Lymphoblastic Leukemia-Lymphoma 299 Leukemia 290 Leukemia, Myeloid, Acute 270 Myelodysplastic Syndromes 263 Lymphoma, Mantle-Cell 228 Lymphoma, Follicular 224 Lymphoma, Large B-Cell, Diffuse 216 Lymphoma, B-Cell, Marginal Zone 206 Burkitt Lymphoma 201 Recurrence 188 Myeloproliferative Disorders 182 Lymphoma, Large-Cell, Immunoblastic 182 Immunoglobulin Light-chain Amyloidosis 162 Primary Myelofibrosis 153 Leukemia, Myeloid, Chronic-Phase 152 Leukemia, Myeloid, Accelerated Phase 143 Lymphoma, T-Cell, Cutaneous 140 Leukemia, Myelomonocytic, Chronic 133 Blast Crisis 131 Mycosis Fungoides 126 Sezary Syndrome 125 Congenital Abnormalities 122 Waldenstrom Macroglobulinemia 121 Leukemia, Hairy Cell 110

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Driving Under the Influence × Plasma cell × Clear all

NCT06659276 2024-10-26

MMR-PET-22-04

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Driving Under the Influence, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡